Glenmark Life Sciences Ltd
NSE:GLS
Wall Street
Price Targets
GLS Price Targets Summary
Glenmark Life Sciences Ltd
According to Wall Street analysts, the average 1-year price target for GLS is 1 214.41 INR with a low forecast of 797.9 INR and a high forecast of 1 428 INR.
Operating Income
Forecast
Operating Income Estimate
Glenmark Life Sciences Ltd
For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's operating income is 9%. The projected CAGR for the next 3 years is 12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GLS's stock price target?
Price Target
1 214.41
INR
According to Wall Street analysts, the average 1-year price target for GLS is 1 214.41 INR with a low forecast of 797.9 INR and a high forecast of 1 428 INR.
What is Glenmark Life Sciences Ltd's Revenue forecast?
Projected CAGR
12%
For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.
What is Glenmark Life Sciences Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's operating income is 9%. The projected CAGR for the next 3 years is 12%.
What is Glenmark Life Sciences Ltd's Net Income forecast?
Projected CAGR
15%
For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's net income is 11%. The projected CAGR for the next 3 years is 15%.
You don't have any saved screeners yet
